- Economic Development
- International Trade
- Research and Development
- Science and Technology
Subject Matter Details
Policies or Program
- Working with the government on an open and inclusive regulatory regime for generic pharmaceuticals that continues to allow the industry to grow in Canada, and discuss with the government how Apotex can work with them to ensure the security and increase the self-sufficiency of Canada’s drug supply.
The lobbyist has arranged or expects to arrange one or more meetings on behalf of the client between a public office holder and any other person in the course of this undertaking.
Global Affairs Canada (GAC)
Health Canada (HC)
House of Commons
Infrastructure Canada (INFC)
Innovation, Science and Economic Development Canada (ISED)
Intergovernmental Affairs Secretariat (IGA)
Prime Minister's Office (PMO)
Privy Council Office (PCO)
Public Safety Canada (PS)
Public Services and Procurement Canada (PSPC)
Transport Canada (TC)
No government funding was received during the last completed financial year.
Client Contact Information
200 Barmac Drive
Toronto, ON M9L 2S8
Heather West, Vice President, Market Access and Government Relations
Parent Company Information
Apotex Inc. is not a subsidiary of any other parent companies.
Coalition Members Information
Apotex Inc. is not a coalition.
Person or Organization with a Direct Interest Beneficiary Information
The activities of Apotex Inc. are not controlled or directed by another person or organization with a direct interest in the outcome of this undertaking.
Subsidiary Beneficiary Information
Apotex Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Public offices held
121 Fentiman Avenue
Ottawa, ON K1N 5M5
Consultant Firm and Address
Loyalist Public Affairs
8 York Street, Suite 200
Ottawa, ON K1N 5S6